|
LRCH1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.790400E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.340300E-02 |
| Normal-vs-Stage2 |
9.327200E-01 |
| Normal-vs-Stage3 |
4.016100E-03 |
| Normal-vs-Stage4 |
7.49030000024575E-07 |
| Stage1-vs-Stage2 |
4.743800E-01 |
| Stage1-vs-Stage3 |
1.550200E-01 |
| Stage1-vs-Stage4 |
1.038700E-03 |
| Stage2-vs-Stage3 |
1.588200E-01 |
| Stage2-vs-Stage4 |
1.832350E-02 |
| Stage3-vs-Stage4 |
1.881620E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.062200E-02 |
| Normal-vs-AfricanAmerican |
3.264400E-01 |
| Normal-vs-Asian |
1.55749999997123E-06 |
| Caucasian-vs-AfricanAmerican |
5.909800E-01 |
| Caucasian-vs-Asian |
2.882800E-03 |
| AfricanAmerican-vs-Asian |
1.155220E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.080000E-02 |
| Normal-vs-Female |
1.905810E-01 |
| Male-vs-Female |
8.858800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.442600E-03 |
| Normal-vs-Extreme_Weight |
2.815600E-02 |
| Normal-vs-Obese |
8.810200E-01 |
| Normal-vs-Extreme_Obese |
3.656600E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.013400E-01 |
| Normal_Weight-vs-Obese |
2.898500E-02 |
| Normal_Weight-vs-Extreme_Obese |
6.014000E-01 |
| Extreme_Weight-vs-Obese |
1.270820E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.838800E-01 |
| Obese-vs-Extreme_Obese |
4.713600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.615450E-01 |
| Normal-vs-Age(41-60Yrs) |
8.917000E-01 |
| Normal-vs-Age(61-80Yrs) |
2.082600E-03 |
| Normal-vs-Age(81-100Yrs) |
5.564400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.554820E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.378200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.825400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.002450E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.461100E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.203200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.106600E-01 |
| Normal-VS-Type2 PRCC |
4.862500E-03 |
| Normal-VS-KIRP CIMP |
4.288199995095E-08 |
| Normal-VS-Unclassified PRCC |
4.303000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.333800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.68199999992258E-07 |
| Type1 PRCC-VS-Unclassified PRCC |
5.688200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.580400E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
4.064800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.823610E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.560820E-03 |
| Normal-vs-N1 |
3.5732000000066E-05 |
| Normal-vs-N2 |
3.91290000000266E-05 |
| N0-vs-N1 |
4.307600E-01 |
| N0-vs-N2 |
2.154200E-01 |
| N1-vs-N2 |
1.747810E-01 |
|
|
